An individual diagnosed with a severe neurological disorder is evaluating two prospective stem cell therapies: the transplantation of adult neural stem cells obtained from a donor, or the use of embryonic stem cells generated via therapeutic cloning (somatic cell nuclear transfer).
Explain the clinical and biological advantages of using embryonic stem cells produced through therapeutic cloning rather than adult stem cells from a donor.
